Astrana Health (ASTH) director exercises 20,000 options at $18.20

Astrana Health (ASTH): A company director exercised stock options and acquired 20,000 shares of common stock at $18.20 on 11/10/2025.

Rhea-AI Filing Summary

Astrana Health (ASTH): A company director exercised stock options and acquired 20,000 shares of common stock at $18.20 on 11/10/2025. Following the transaction, the director directly owns 34,763 shares. This total includes 6,449 restricted shares that will vest on the earlier of June 11, 2026 or the company’s 2026 annual meeting of stockholders. The exercised option covered 20,000 underlying shares and now shows a remaining balance of 0.

Insider Trade Summary

20,000 shares exercised/converted

Exercise 2 txns

Insider Mazdyasni Matthew

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to Buy)	20,000	$0.00	$0.00
Exercise	Common Stock	20,000	$18.20	$364K

Holdings After Transaction: Stock Option (right to Buy) — 0 contracts (Direct); Common Stock — 34,763 shares (Direct)

Footnotes (2)

1. F1. Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.
2. F2. These stock options were fully vested and exercisable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ASTH report on Form 4?

A director exercised stock options and acquired 20,000 common shares at $18.20 on 11/10/2025.

How many ASTH shares does the reporting person now own?

Direct beneficial ownership is 34,763 shares following the transaction.

Were any restricted shares disclosed in the ASTH filing?

Yes. The total includes 6,449 restricted shares that vest on the earlier of June 11, 2026 or the 2026 annual meeting.

What happened to the exercised ASTH stock option position?

The option covering 20,000 underlying shares was exercised and now shows 0 derivative securities remaining.

What was the exercise price for the ASTH options?

The exercise price was $18.20 per share.

What is the insider’s relationship to Astrana Health (ASTH)?

The reporting person is a Director of the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/12/2025 - 05:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mazdyasni Matthew

(Last) (First) (Middle)

C/O ASTRANA HEALTH, INC.

1668 S. GARFIELD AVE, 2ND FLOOR

(Street)

ALHAMBRA CA 91801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/10/2025		M		20,000	A	$18.2	34,763(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to Buy)	$18.2	11/10/2025		M			20,000	(2)	11/11/2025	Common Stock	20,000	$0	0	D

Explanation of Responses:

1. Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.

2. These stock options were fully vested and exercisable.

	/s/ Kathy Diep, as Attorney-in-Fact	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.